![Parand Darou Pharma](https://www.pharmacompass.com/image/flap/parand-darou-desktop-headergif-12950.gif)
![Parand Darou Pharma](https://www.pharmacompass.com/image/flap/parand-darou-mobgif-20656.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/18/2900811/0/en/Gyre-Therapeutics-Announces-Publication-in-Journal-of-Gastroenterology-and-Hepatology.html
https://www.globenewswire.com/news-release/2024/05/30/2891131/0/en/Gyre-Pharmaceuticals-Receives-IND-Approval-from-China-s-NMPA-to-Evaluate-F230-for-the-Treatment-of-Pulmonary-Arterial-Hypertension.html
https://www.globenewswire.com/news-release/2024/05/28/2889411/0/en/Gyre-Therapeutics-Announces-Expected-Addition-to-the-Russell-2000-and-Russell-3000-Indexes.html
https://www.globenewswire.com/news-release/2024/05/09/2879221/0/en/Gyre-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
https://seekingalpha.com/article/4683596-gyre-therapeutics-under-radar-biotech-shot-at-mash-approval-in-time-stock
https://www.globenewswire.com/news-release/2024/03/26/2852182/0/en/Gyre-Therapeutics-Reports-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/03/21/2850088/0/en/Gyre-Therapeutics-Expands-Board-of-Directors-with-Appointment-of-Rodney-L-Nussbaum.html